Medical cannabis and driving
Medical cannabis use is increasingly common in Australia. Patients and physicians need to be aware of the important implications that such use may have for driving.
Most British people would now consider using medical cannabis, survey shows
Most British people would consider using cannabis to treat medical conditions, particularly if prescribed by a doctor, a new study has shown.
Medical Cannabis in Asthmatic Patients
With the increased use of cannabis in the medicinal and recreational domains, it is becoming more important for physicians to better understand its harmful and beneficial effects.
Medical cannabis use may be common in women experiencing menopause-related symptoms
The legalization of medical cannabis has led to its use in treating a growing number of health problems.
Research Finds Cannabis Effective for Migraines
Cannabis preparations are likely effective at preventing and treating migraines, according to a recently published review of available research.
Medical Cannabis Use: Exploring the Perceptions and Experiences of Older Adults with Chronic Conditions
Although the rate of cannabis use by older adults is increasing more quickly than all other age groups, little is known about the reasons older adults use cannabis and the outcomes they experience.
Research Finds Cannabis Effective for Migraines
Cannabis preparations are likely effective at preventing and treating migraines, according to a recently published review of available research.
Unlocking CBN
Californian Scientists Unlock the Power of Using Cannabinol (CBN) to Protect Against Neurodegenerative Diseases
Anesthetic considerations in medical cannabis patients
Growing numbers of patients, consuming cannabinoids admitted to surgery, create a challenge to anesthesia providers
Councillor shares ‘life-changing experience’ from medically-prescribed Cannabis as she hopes to break stigma
A South Ayrshire councillor has spoken about the positive impact medically-prescribed Cannabis has had in her life as she hopes to break the stigma and address financial costs surrounding the drug.